U.S. drug pricing watchdog gets funding to expand efforts

(Reuters) - A U.S. independent nonprofit organization that evaluates the clinical and cost effectiveness of new medicines said on Tuesday it has received significant new funding that will enable it to greatly expand its work.

from Reuters: Health News http://ift.tt/2gZaTVu